Carbetocin versus Oxytocin for prevention of postpartum hemorrhage at cesarean sectio
Phase 3
- Conditions
- postpartum hemorrhage.Postpartum care and examination
- Registration Number
- IRCT2015050919644N1
- Lead Sponsor
- Vice Chancellor for research, Zahedan University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 90
Inclusion Criteria
Pregnant women with single pregnancy one previous cesarean section or primary cesarean and candidate for cesarean delivery & application of spinal anesthesia.
5-Exclusion criteria: Other reason of PPH except atonia; Presence of preeclampsia; hypotension; heart disease and asthma; Presence of risk factor of PPH such as uterine fibroid? previous myomectomy? placenta previa? past history of PPH? chorioamnionitis; fetal macrosomia and fetal malformations associated with polyhydramnios
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemoglobin level. Timepoint: Before and 6 and 12hours after cesarean delivery. Method of measurement: Hemoglobine assessment.
- Secondary Outcome Measures
Name Time Method terine tone. Timepoint: 2 and 12 and 24 hours after cesarean delivery. Method of measurement: Assessment of uterine tone.;Need to adminestration of utertonic drug. Timepoint: During 24 hours after cesarean delivery. Method of measurement: Dosage and amount of drug.;Adverse effects. Timepoint: During 24 hours after cesarean delivery. Method of measurement: Observation of adverse effects.